BioSpace News Archive

As GSK moves into the new year, Chief Executive Officer Emma Walmsley predicted 2022 will be a “landmark year” for the company.

Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

REGENXBIO presented results from its ongoing Phase I/II trial of RGX-111, an investigational one-time gene therapy for people with Mucopolysaccharidosis Type I (MPS I).

Statistically significant weight loss and liver fat reduction were seen across all dosage groups—with no changes to diet or exercise.

An entire lot of the male erectile dysfunction drug The Red Pill is being pulled out of the market following the discovery that it contains some traces of tadalafil.

A week after Novavax submitted its Emergency Use Authorization materials to the FDA for its COVID-19 vaccine candidate. reports are coming out about the company’s problems with the production and delivery.

Mawi DNA Technologies, a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications.

Dr. Reddy’s Laboratories Ltd. announced the launch of its authorized generic version of Par Pharmaceutical’s VASOSTRICT® Vials in the U.S. Market approved by the U.S. Food and Drug Administration.

Hoth Therapeutics, Inc. today announced it has signed an agreement with NUVISAN, a European CRO/CDMO with topical manufacturing capabilities in Sophia-Antipolis, France , to manufacture clinical batches of HT-001.

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Pfizer’s Hospital leadership team – Angela Lukin, Global President; Annaliesa Anderson, Ph.D., Chief Scientific Officer; and James Rusnak, M.D., Ph.D., Chief Development Officer – at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 1:00 p.m. Eastern Standard Time.